Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Ascendis Pharma ADR
(NQ:
ASND
)
129.90
+3.24 (+2.56%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ascendis Pharma ADR
< Previous
1
2
3
4
5
6
7
Next >
NASDAQ: ASND Investor Alert: Investigation over Potential Wrongdoing at Ascendis Pharma A/S
June 20, 2023
San Diego, CA -- (SBWIRE) -- 06/20/2023 -- Certain directors of Ascendis Pharma A/S are under investigation over potential breaches of fiduciary duties by certain directors.
Via
SBWire
Bragar Eagel & Squire, P.C. Is Investigating C3.ai, Ascendis, Alvotech, and Shift4 and Encourages Investors to Contact the Firm
June 19, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
The Latest Analyst Ratings for Ascendis Pharma
June 01, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
May 01, 2023
Via
Benzinga
FDA Rejects Ascendis Pharma's TransCon PTH For Hypoparathyroidism
May 01, 2023
The FDA issued a complete response letter (CRL) for Ascendis Pharma A/S's
Via
Benzinga
Why Shares of Ascendis Pharma Are Climbing Monday
May 01, 2023
A critical response letter from the FDA means hope remains for the company's hyperthyroidism therapy candidate.
Via
The Motley Fool
Why Ascendis Pharma Stock Is Crashing This Week
April 06, 2023
The FDA put a roadblock in the path to market for Ascendis' hypoparathyroidism drug.
Via
The Motley Fool
Analyst Ratings for Ascendis Pharma
April 03, 2023
Via
Benzinga
US Stocks Rise; Norwegian Cruise Line Posts Q1 Results
May 01, 2023
U.S. stocks traded higher this morning, ahead of the Federal Reserve’s monetary policy meeting. Following the market opening Monday, the Dow traded up 0.15% to 34,147.97, while the NASDAQ inched up...
Via
Benzinga
IVERIC bio, Ascendis Pharma And Other Big Stocks Moving Higher In Monday's Pre-Market Session
May 01, 2023
U.S. stock futures traded mixed this morning. Here are some big stocks recording gains in today’s pre-market trading session. Apollomics, Inc. (NASDAQ: APLM) surged 58.4% to $7.35 in pre-market trading...
Via
Benzinga
Bragar Eagel & Squire, P.C. Is Investigating Fox, Ascendis, and Shift4 and Encourages Investors to Contact the Firm
April 28, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
Hedge Funds Fall Short: Underperforming Low-Cost S&P 500 ETF By 6% In 2023. Here's Why.
April 20, 2023
So far, 2023 has not started well for the hedge fund sector, as a common SPDR S&P 500 Trust ETF (ARCA: SPY) fared much better than the Global X Guru Index ETF (ARCA: GURU), a fund that invests in the...
Via
Benzinga
Why Ascendis Pharma Stock Is Plunging Today
April 03, 2023
A regulatory hiccup is weighing on the biopharma's shares today.
Via
The Motley Fool
Ascendis Pharma Flags Regulatory Delay In US For Its Hypoparathyroidism Candidate
April 03, 2023
Via
Benzinga
NASDAQ: ASND Shareholder Notice: Investigation over Possible Securities Laws Violations by Ascendis Pharma A/S
April 17, 2023
San Diego, CA -- (SBWIRE) -- 04/17/2023 -- Ascendis Pharma A/S is under investigation over potential securities laws violations in connection with certain financial statements.
Via
SBWire
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Ascendis Pharma Investors to Inquire About Securities Class Action Investigation - ASND
April 14, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
Product Safety
10 Health Care Stocks With Whale Alerts In Today's Session
April 12, 2023
Via
Benzinga
ASCENDIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Ascendis Pharma A/S on Behalf of Ascendis Stockholders and Encourages Investors to Contact the Firm
April 07, 2023
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For April 5, 2023
April 05, 2023
Via
Benzinga
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Ascendis Pharma A/S (ASND) Investigation
April 04, 2023
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Ascendis Pharma A/S and Encourages Investors with Losses to Contact the Firm
April 04, 2023
From
The Schall Law Firm
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For April 4, 2023
April 04, 2023
Via
Benzinga
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Ascendis Pharma A/S and Encourages Investors with Losses to Contact the Firm
April 03, 2023
From
The Schall Law Firm
Via
Business Wire
Nasdaq Down 80 Points; VirTra Shares Spike Higher
April 03, 2023
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite dropping around 80 points on Monday. The Dow traded up 0.89% to 33,571.43 while the NASDAQ fell 0.66% to 12,142.07. The S&P...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
April 03, 2023
Via
Benzinga
Dow Up Triple Digits As Second Quarter Kicks Off
April 03, 2023
The Dow Jones Industrial Average is up 146 points midday to kick off the second quarter, while the S&P 500 Index inches lower, and the Nasdaq Composite sits firmly in the red.
Via
Talk Markets
Crude Oil Jumps Over 6%; OncoSec Medical Shares Plummet
April 03, 2023
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite dropping more than 100 points on Monday. The Dow traded up 0.58% to 33,468.38 while the NASDAQ fell 0.96% to 12,104.67. The...
Via
Benzinga
Tesla, NIO And Other Big Stocks Moving Lower On Monday
April 03, 2023
U.S. stocks traded mixed, with the Dow Jones gaining around 200 points on Monday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Why Heska Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 03, 2023
Gainers Nogin, Inc. (NASDAQ: NOGN) shares surged 172.4% to $7.41. Guardforce AI Co., Limited (NASDAQ: GFAI) jumped 101% to $14.24 after climbing 50% on Friday.
Via
Benzinga
Ascendis Stock Plunges As FDA Identifies Deficiencies In Company's New Drug Application
April 03, 2023
The FDA decision prevents Ascendis from labeling and marketing the new drug application for TransCon PTH. ASND stock plunged
Via
Investor's Business Daily
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.